Stay updated with breaking news from Mobile Processing Units. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Morgenesis LLC, the US point of care (POCare) services subsidiary of global cell and gene therapies developer biotech Orgenesis, has signed an agreement with contract development and manufacturing organisation SCTbio to open new POCare sites within the Czech Republic. Click to read more...
GERMANTOWN, Md., March 30, 2022 -- Orgenesis Inc. , a global biotech company working to unlock the full potential of cell and gene therapies, today reports its financial results for the year ended... | March 30, 2022
“Theracell has proven to be an ideal partner for Orgenesis, contributing extensive experience and capabilities in autologous cell therapy and...
Orgenesis teams with Dong-a University Hospital in South Korea and Cure Therapeutics to utilize its Mobile Processing Units and Labs, or OMPULs OMPULs are multi-purpose mobile autonomous good manufacturing practice facilities intended to develop, optimize, and manufacture cell and gene therapies at the point of use The latest collaboration follows a recent joint venture agreement between Orgenesis and Cure Therapeutics to target cancer and infectious diseases Orgenesis Inc (NASDAQ:ORGS) (FRA:45O) announced Monday it has signed a collaboration agreement with Dong-a University Hospi...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Proactive news headlines including Altamira Gold, AIM ImmunoTech, QC Copper and Gold and Cloud ... Proactive InvestorsMarch 8, 2021 GMT New York, March 08, 2021 (GLOBE NEWSWIRE) -- - Altamira Gold Corp (CVE:ALTA) (OTCPINK:EQTRF) (FRA:T6UP) reveals four high-grade gold and silver vein structures at its Apiacas project in Brazil click here - Orgenesis Inc (NASDAQ:ORGS) (FRA:45O) teams with Dong-a University Hospital in South Korea and Cure Therapeutics to utilize its Mobile Processing Units and Labs...